| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 1,720 | 2,066 | ||
| Prepaid expenses and other current assets | 107 | 167 | ||
| Total current assets | 1,827 | 2,233 | ||
| Operating lease right-of-use assets | 73 | 82 | ||
| Digital assets | 325 | - | ||
| Intangible asset | 2,039 | 2,039 | ||
| Other assets | 3 | 3 | ||
| Total assets | 4,267 | 4,357 | ||
| Accounts payable and accrued liabilities | 3,868 | 4,841 | ||
| Due to related parties | 32 | 26 | ||
| Operating lease liabilities - current portion | 39 | 36 | ||
| Convertible notes | - | 791 | ||
| Accrued interest - convertible notes | 46 | 18 | ||
| Convertible notes | 875 | - | ||
| Total current liabilities | 4,860 | 5,712 | ||
| Operating lease liabilities | 40 | 51 | ||
| Total liabilities | 4,900 | 5,763 | ||
| Common stock, par value 0.001, 500,000,000 shares authorized and 1,555,493 and 567,582 shares issued and outstanding as of september 30, 2025, and december 31, 2024, respectively | 2 | 1 | ||
| Additional paid-in capital | 58,491 | 54,617 | ||
| Accumulated deficit | -58,849 | -55,729 | ||
| Accumulated other comprehensive loss | -277 | -295 | ||
| Total stockholders' (deficit) equity | -633 | -1,406 | ||
| Total liabilities and stockholders' (deficit) equity | 4,267 | 4,357 | ||
ARTELO BIOSCIENCES, INC. (ATLEW)
ARTELO BIOSCIENCES, INC. (ATLEW)